2 More Drugs Recommended To Treat Covid In UK, But Not In US – Kaiser Health News
Posted: January 12, 2021 at 5:53 am
The nations have conflicting research results on Roches Actemra and Sanofi and Regenerons Kevzara. The United Kingdom says the anti-inflammatory drugs significantly reduce the risk of death in covid patients needing intensive care.
FiercePharma:Roche's Actemra, Regeneron's Kevzara Win U.K.'s Favor In COVID-19 After Study Shows 24% Drop In Death RiskThe question of whether seriously ill COVID-19 patients can benefit from anti-inflammatories like Roches Actemra and Sanofi and Regenerons Kevzara has dogged practitioners in the United States thanks to conflicting clinical trial results. The United Kingdom, on the other hand, has reached a definitive answer on the two drugs, both of which are IL-6 inhibitors: They significantly reduce the risk of death in COVID-19 patients needing intensive care, and they should be used to ease the pressure hospitals are now facing as the coronavirus pandemic continues to intensify, the countrys National Institute for Health Research (NIHR) said Thursday. The recommendation came after data from an NIHR-sponsored study showed that Actemra and Kevzara can cut hospital stays for COVID-19 patients admitted to intensive care by 10 days and can lower the risk of death by 24% in patients who receive either drug within a day of admission. (Weintraub, 1/8)
Albuquerque Journal:NM Providers Slow To Prescribe Coronavirus Antibody DrugsNew antibody drugs are available around the state that, if given early, can dramatically reduce the chance of at-risk COVID-19 patients getting so sick they end up in the hospital. But there havent been a lot of takers in New Mexico despite a near-record of 43 daily deaths one day last week related to COVID-19. Now the push is on to educate patients and medical providers about the availability and effectiveness of the two IV-administered antibody therapies. (Heild, 1/10)
Fortune:Bayer Strikes Deal To Aid CureVac In COVID-19 Vaccine RolloutThe German biopharma firm CureVac has announced a tie-up with the country's biggest pharmaceutical beast, Bayer, for the development and supply of CureVac's candidate COVID-19 vaccine. The companies did not disclose the financial terms of the deal. Bayer's stock jumped more than 2% on the news Thursday morning. The collaboration and services agreement should aid the supply of "several hundred million" vaccine doses, the companies said. CureVac said in November that it intends to produce up to 300 million doses this year, and up to 600 million doses in 2022. (Meyer, 1/7)
FiercePharma:Look Out, Pharma. A 'Tidal Wave' Of Side Effect Reports Is Coming Amid COVID-19 Vaccine RolloutsWith COVID-19 vaccine launches gaining steamand an unprecedented level of media coverage zeroed inpharma companies of all stripes should brace not only for a wave of adverse event reports, experts say, but for lawsuits that could follow. With tens of millions of Americansset to be vaccinated, including many people athigh risk of severe COVID-19, it's not just vaccine makers who need to actively look out for potential adverse events or drug interactions, lawyers with Sidley Austin said. All pharma companiesnot just those involved in COVID-19 vaccine deliveriescanexpect a significant increase in volume of reports over the coming months,Torrey Cope, a partner in the firm'sFood, Drug and Medical Device Regulatory practice,said in an interview. (Sagonowsky, 1/7)
ProPublica:CDC Shut Down A Lab Involved In Making Faulty Coronavirus TestsWith no public notice, the Centers for Disease Control and Prevention in October shut down a key lab involved in making faulty COVID-19 tests for state and local health authorities early in the pandemic. The move came less than six hours after ProPublica published an investigation that detailed for the first time the chain of mistakes and disputes that unfolded inside CDC labs, which culminated in one of the biggest fumbles in the agencys 74-year history. A CDC acting branch chief told the staff of the Respiratory Viruses Diagnostics Team lab on Oct. 15 that the closure would be for two to four weeks while the CDC investigated and the staff worked on corrective action plans, according to internal sources. But more than two months later, the lab still is not performing tests. (Bandler, Callahan and Rotella, 1/8)
In other pharmaceutical industry news
FiercePharma:FDA Extends Immunodeficiency Drug's Shelf Life As Pandemic Exacerbates ShortagesThe U.S. immunoglobulinsupplyjust got alittle more secure, thanks to a label change enablingone of Octapharma's chief rare disease meds to sitin the fridge for up to three years.The FDA has stretched the expiration date of 42 existing lots of Octapharmas subcutaneous immune deficiency drug cutaquigand granted a 12-month shelf life extension on future lots stored at 36 degrees to 46 degrees Fahrenheit. The drug was previously cleared to last 24 months when refrigerated. Cutaquigs six-month shelf life at room temperature remains unchanged, Octapharma said Tuesday. (Kansteiner, 1/6)
Stat:FDA Advisory Panel Meetings Became "Rarer And Tougher" In 2020Among the myriad changes wrought by the Covid-19 pandemic, Food and Drug Administration advisory committee meetings to review medicines are rarer and tougher now, according to one Wall Street analyst. Over the past year, just half of new drug applications taken to advisory committees were recommended for regulatory approval. That compares with 78% in 2019 and a rate of more than 80% in three of the four years before that, according to Cowen analyst Rick Weissenstein, who cited an analysis by the Prevision Policy consulting firm in an investor note. (Silverman, 1/8)
FiercePharma:Should Pharma Charity Contributions Be Publicly Disclosed, Just Like Doctor Payments? Senators Say YesPharma companies have inked a series of federal settlements over payments to charity organizations, which the federal government argues are a conduit to boosting drug sales. Now, after an opioid investigation, two Senators want all those charity payments disclosed publicly. And they have just the mechanism for it. Sens. Chuck Grassley and Ron Wyden have calledforan expansion of theCenters for Medicare and Medicaid Services Open Payments database. Thatdatabase now includespayments from pharma companies to doctors and other medical providers, but the senators propose adding payments to tax-exempt groups, too. Further, the senators have called for anew requirement that the HHS secretary formulate guidelines to boost transparency aroundresearch organizations and others contracted by the health agency. (Sagonowsky, 1/8)
CIDRAP:Nations Facing Drug Shortages Use Registries, Other StepsDrug supply chain vulnerabilities have achieved greater visibility with the COVID-19 pandemic, but they have increasingly plagued countries in the past few years. A survey published in Health Policy's December issue found that 20 of 24 countries used drug registries to combat them, 20 simplified regulatory procedures during shortages, 18 regularly talked with stakeholders, and 15 had financial sanctions in place for when manufacturers missed notification or supply requirements. Even with these practices in place, multiple countries expressed an interest in increasing management strategies, and for good reason. Finland, the researchers report, experienced an 18-fold increase in shortages from 2010 to 2018, with instances doubling from 2016 to 2018 alone. (McLernon, 1/8)
See original here:
2 More Drugs Recommended To Treat Covid In UK, But Not In US - Kaiser Health News
- Springfield National Weather Service radar scheduled outage coming, will last about a week - KOLR - OzarksFirst.com - February 25th, 2021
- Global Military Aircraft Modernization and Upgrade and Retrofit Markets to 2024: Incorporation of CNS Systems in aircraft and Emergence of SVAB -... - February 25th, 2021
- Real-Time Communication with Dreaming Person Possible, Says Study | The Weather Channel - Articles from The Weather Channel | weather.com - The... - February 25th, 2021
- Canned Soups Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, Category, Processing, and Distribution Channel - GlobeNewswire - February 25th, 2021
- Star Royalties Closes Second US$6 Million Installment of US$18 Million Stream Financing for the Restart of the Copperstone Gold Mine - Junior Mining... - February 25th, 2021
- Norwegian Army Adding 20 CV90s to Its Fleet - Business Wire - February 25th, 2021
- Calico Purring Right Along With Life Extension Research - Nanalyze - February 1st, 2021
- Get healthy in Feb. with AgriLife - Pleasanton Express - February 1st, 2021
- Wellness Supplements Market Statistics 2021- Industry Insights and COVID-19 impact analysis with Future Opportunities 2027 | Life Extension, OPTAVIA,... - February 1st, 2021
- Great Panther Files NI 43-101 Technical Report for the Tucano Gold Mine and Provides Update on Exploration Strategy and Programs for 2021 - PRNewswire - February 1st, 2021
- Sweden Looks to the Past to Prepare for Its Defense Future - Defense & Security Monitor - January 29th, 2021
- Yamana Gold Provides 2021-2023 Guidance and Ten-Year Overview - GlobeNewswire - January 29th, 2021
- Here are the challenges involved in building the future US Navy - DefenseNews.com - January 25th, 2021
- Divine Flavor adopts StePac' modified atmosphere standing pouches for extending produce shelf life in the retail sector - PRNewswire - January 25th, 2021
- miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team -... - January 25th, 2021
- Capstone Advances Two Operational Growth Projects to Sustain 200 Mlbs Copper Production Starting in 2022 - Business Wire - January 25th, 2021
- The Venture Bros: 10 Biggest Twists In The Series | CBR - CBR - Comic Book Resources - January 12th, 2021
- DNA-editing method shows promise to treat mouse model of progeria - National Human Genome Research Institute - January 9th, 2021
- Digital twins and design innovation - Engineer Live - January 9th, 2021
- Harpoon Therapeutics : Clin Cancer Res 2021; OnlineFirst version Jan 6, 2021 - Marketscreener.com - January 9th, 2021
- Massive Science Year in Review: 2020 edition - Massive Science - January 9th, 2021
- Panthera began dosing volunteers in AstraZeneca's phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its... - January 9th, 2021
- National Guard troops to take back seat as Trump addresses supporters rallying to his call to overturn the election - Washington Examiner - January 9th, 2021
- Several AF fighter jets, combat helicopters to be overhauled to boost air power - Daily Mirror - January 9th, 2021
- Looking At Year Seven On This Cancerversary - Curetoday.com - January 5th, 2021
- JPT Mature Fields and Well Revitalization - Journal of Petroleum Technology - January 5th, 2021
- The 6 big military space stories of 2020 - C4ISRNet - January 5th, 2021
- Comprehensive Report on Magnolia Bark Extract Market 2021 | Trends, Growth Demand, Opportunities & Forecast To 2027 - LionLowdown - January 5th, 2021
- Midlife refit of Scripps' Research Vessel Roger Revelle completed - Research vessel (R/V) Roger Revelle is back at work after a midlife refit... - January 5th, 2021
- 2020: A year of challenge and achievement for Indian nuclear sector - The Siasat Daily - January 5th, 2021
- Equinor stakes NOK 3 billion to improve Statfjord Ost oil recovery - WorldOil - December 28th, 2020
- Antibody study aims to protect those exposed to coronavirus from illness - The Jerusalem Post - December 28th, 2020
- Five Persistent Misconceptions About Modernizing The US ICBM Force - Forbes - December 28th, 2020
- Commercial constellations don't live up to the hype: Euroconsult - SatelliteProME.com - December 14th, 2020
- Global Antioxidant Supplement Market Proceeds To Witness Huge Upswing Over Assessment Period by 2025 - The Courier - December 14th, 2020
- The end of coal? Why investors aren't buying the myth of the industry's 'renaissance' - The Guardian - December 14th, 2020
- Fiore Gold Reports Two Year Mine Life Extension at Its Pan Mine, Nevada - Yahoo Finance - December 10th, 2020
- Crescendo Biologics Expands its Ongoing Collaboration with Takeda - Business Wire - December 10th, 2020
- The 10 Best Creatine Supplements in 2020 - Healthline - December 10th, 2020
- EPZ calls for continued nuclear power in the Netherlands - Nuclear Engineering - December 10th, 2020
- The Global Military Aircraft Modernization and Upgrade and Retrofit Market is expected to grow by $ 2.61 bn during 2020-2024 progressing at a CAGR of... - December 10th, 2020
- Controlled Intelligent Packaging, Preservation and Shelf-Life Extension Market to Witness Widespread Expansion During 2020 to 2026 Cargill Inc.... - December 10th, 2020
- Shelf Life Extension Ingredients Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2028 - Murphy's Hockey Law - December 10th, 2020
- SABCS: Novartis touts Kisqali's 5-year breast cancer survival, advantage over Pfizer's Ibrance - FiercePharma - December 10th, 2020
- Satellite capacity pricing declines slow, but price pressure expected to increase with new supply entering service in 2023 - Geospatial World - December 6th, 2020
- Team Trump's 2022 budget plan; COVID canks conference; Raytheon, C3.ai team up; and more. - Defense One - December 6th, 2020
- Researchers Think Megastructures Can Help Seed Life Throughout the Galaxy - VICE - December 6th, 2020
- Dehydroepiandrosterone(DHEA) Market 2020-2025 with Growth Factors and Trends with Focusing Key players like BulkSupplements, Natrol, Jarrow Formulas,... - December 6th, 2020
- Shelf Life Extension Ingredients Market Analysis of Key Players, End User, Demand and Consumption By 2028 - The Haitian-Caribbean News Network - December 1st, 2020
- Lubbock weather radar to be down for 2 weeks - Plainview Daily Herald - November 28th, 2020
- Switzerland extends life of CV90s - Jane's - November 28th, 2020
- Impact of COVID-19 on Oral Probiotics Market 2020 Industry Insight, Segment by Key Companies, Countries, Types, Applications and Forecast to 2026 -... - November 28th, 2020
- Incremental Sales to Drive the Cold Plasma Market by 2026 - The Market Feed - November 28th, 2020
- Flight Tests to Show B61-12 Will Work on Air Force's Newest Fighter Jet - I-Connect007 - November 26th, 2020
- An F-35A Dropped An Inert B61-12 Nuclear Bomb During Supersonic Flight For The First Time - The Aviationist - November 26th, 2020
- Flight tests to show B61-12 will work on Air Forces newest fighter jet - Newswise - November 26th, 2020
- Global Bilberry Extract Products Market To Witness Huge Gains Over 2020-2026 - The Courier - November 26th, 2020
- Traditional launch services may not suit the needs of the future Space Force - SpaceNews - November 26th, 2020
- Natural sleeping pills: What are they? - Medical News Today - November 23rd, 2020
- Adagio Therapeutics COVID-19 Antibody Demonstrates Best-in-Class Breadth and Potency Against a Range of Coronaviruses that Pose Human Threat |... - November 23rd, 2020
- Infrastructure and Energy Alternatives, Inc. Extends Service Offering to Wind Customers Through Formation of New Renewable Energy Services Group -... - November 23rd, 2020
- Family fight to make more memories with daughter after pandemic robs them of precious time - North Wales Live - November 23rd, 2020
- NY Power Authority Announces First Milestone of Project to Extend Operating Life of New York's Largest Power Plant - Automation.com - November 18th, 2020
- Cryonics Technology Market Size & Revenue Analysis | Praxair, Cellulis, Cryologics, Cryotherm, KrioRus - The Think Curiouser - November 18th, 2020
- Minot's weather radar will be out of service for approximately one week for scheduled upgrades - Minot Daily News - November 18th, 2020
- Cryonics Technology Market 2020 to Global Forecast 2023 By Key Companies Praxair, Cellulis, Cryologics, Cryotherm, KrioRus, VWR, Thermo Fisher... - November 18th, 2020
- Inside The Navy's Top Aggressor Squadron That Is About To Trade Its Hornets For Super Hornets - The Drive - November 18th, 2020
- Antioxidant Supplement Market Bolstered by Emerging New Advancements, Says QYR | NOW, Vibrant Health, AST R-ALA, GNC - The Think Curiouser - November 18th, 2020
- Why Blade Runner is the best sci-fi movie of all time - Looper - November 18th, 2020
- Column: Just How Old Is 'Old Age' in The Future? - Southern Pines Pilot - November 8th, 2020
- Oral Probiotics Market Outlook, Global Key Players and Covid-19 Impact by 2026 | Oragenics, Life Extension, TheraBreath and Others - TechnoWeekly - November 8th, 2020
- 10 Sci-Fi Movies That Only Make Sense On A Rewatch | ScreenRant - Screen Rant - November 8th, 2020
- Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 and Updates Full Year 2020 Guidance - Yahoo... - November 5th, 2020
- Insights on the In-Space Manufacturing, Servicing, and Transportation Global Market to 2030 - Increasing Developments in On-Orbit Space Capabilities... - November 5th, 2020
- MJR completes work on TSHD Heortnesse - Dredging Today - November 5th, 2020
- Global Glucose Tolerance Test Market 2020 Covid 19 Analysis, Market Size, Market Growth, Competitive Strategies, and Worldwide Demand 2027 - BCFocus - November 5th, 2020
- Lingonberry Extract Market: Qualitative analysis of the leading players and competitive industry scenario | Shanghai Freemen, Natrol, Source Naturals,... - November 5th, 2020
- Cryonics Technology Market 2020 Industry Size, Trends, Global Growth, Insights And Forecast Research Report 2025 - The Think Curiouser - November 5th, 2020
- Antioxidant Supplement Market 2026 Industry Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global... - November 5th, 2020
- Impact Of Covid 19 On Bilberry Extract Products Market 2020 Industry Challenges Business Overview And Forecast Research Study 2026 - TechnoWeekly - November 5th, 2020